Summit Therapeutics SMMT FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's FX effect on cash?
- Summit Therapeutics (SMMT) reported FX effect on cash of -$19K in Q1 2026.
- How has Summit Therapeutics's FX effect on cash changed year-over-year?
- Summit Therapeutics's FX effect on cash decreased by 150.0% year-over-year, from $38K to -$19K.
- What does FX effect on cash mean?
- The change in cash value caused by currency exchange rate fluctuations.
- How do you interpret FX effect on cash?
- This is largely an accounting adjustment; large values may indicate significant exposure to foreign currency volatility in international operations.
- How does FX effect on cash compare across companies?
- Standard for any company with international operations; peers report this as a standard reconciliation item in the cash flow statement.